Board of Directors

Board of Directors
Home / About Protalix / Board of Directors

Board of Directors

Zeev Bronfeld

Chairman
-more-

Mr. Bronfeld has served as the Chairman of our Board of Directors since August 2019.  He has served on our Board of Directors since December 2006 and as a director of Protalix Ltd. since 1996. Mr. Bronfeld brings to us vast experience in management and value building of biotechnology companies. He is an experienced businessman who is involved in a number of biotechnology companies. He was a co-founder of Bio-cell Ltd., a former Israeli publicly-traded holding company that specialized in biotechnology companies and served as its Chief Executive Officer from 1986 through 2015. Mr. Bronfeld currently serves as a director of Entera Bio Ltd., as well as The Trendlines Group, D.N.A. Biomedical Solutions Ltd. and Electreon Wireless Ltd. (formerly, Biomedix Incubator Ltd.), all of which are public companies. Mr. Bronfeld is also a director of a number of privately-held companies, most of which are involved in the life sciences, such as Contipi Medical Ltd and TransBiodiesel Ltd. From 2008 through January 2017, Mr. Bronfeld served as a director of Macrocure Ltd., a Nasdaq-listed company that merged into Leap Therapeutics, Inc.  Mr. Bronfeld received a B.A. in Economics from the Hebrew University in 1975.

Dror Bashan

President & Chief Executive Officer, Director
-more-

Mr. Bashan has served as our President and Chief Executive Officer and as a director of our company since June 2019.  He has over 20 years of experience in the pharmaceutical industry with roles ranging from business development, marketing, sales and finance providing him with both cross regional and cross discipline experience and a deep knowledge of the global pharmaceutical and health industries.  From 1998 through 2018, he served in a number of senior positions at Teva Pharmaceutical Industries Ltd.  Most recently, he served as Teva’s Senior Vice President, Global Business Development, and was involved in strategic alliances, cross-company strategic projects and the acquisition and divestiture of assets.  Mr. Bashan holds a BA in Economics and Business Management from the Tel Aviv University and an MBA from the Tel-Aviv University.

David Granot

Director
-more-

Mr. Granot has served as our director since August 2018.  Mr. Granot currently serves on the Board of Directors of Ormat Technologies, Inc., and of Bezeq Israeli Telecommunication, Co. Ltd. since May 22, 2012, where he served as temporary Acting Chairman, July 2017 through May 2018.  He also serves on the Board of Directors of Alrov Properties & Lodgings Ltd.; and Jerusalem Economy Ltd., each of which is an Israeli public company.  He also serves on the board of directors of Tempo Beverages Ltd. and Geregu Power PLC, each of which is a privately-held company.  From 2009 through 2017, he was a director of Harel Insurance Investments and Financial Ltd. and Chairman of the Nostro investment committee of Harel Insurance.  In addition, from 2001 through 2007, he served as the Chief Executive Officer of the First International Bank of Israel Ltd, from 1998 through 2000 he served as the Chief Executive Officer of the Israel Discount Bank and from 1995 through 1998 he served as the Chief Executive Officer of the Israel Union Bank.  He holds a B.A. in Economics and an MBA, both from the Hebrew University of Jerusalem.

Amos Bar Shalev

Director
-more-

Mr. Bar Shalev has served as our director since July 2008.  Previously, Mr. Bar Shalev served as a director of Protalix Ltd. from 2005 through January 2008, and as our director from 2006 through 2008.  Mr. Bar Shalev brings to us extensive experience in managing technology companies.  Currently, Mr. Bar Shalev serves on the boards of directors of Aposense Ltd., an Israeli publicly-traded company listed on the TASE, since 2011, as well as Twine Solutions Ltd., a privately-held technology company, since 2015, and of Steam CC Ltd., since 2017, both privately-held Israeli companies.  From 2004 through 2012, Mr. Bar Shalev served as a director of Technorov Holdings (1993) Ltd. and managed its portfolio.  In addition, he served on the board of directors of Highcon Systems Ltd., a privately-held Israeli company, from 2010 through 2012.  From 1997 through 2004, he was a Managing Director of TDA Capital Partners, a management company of the TGF (Templeton Tadiran) Fund.  From 2004 through 2007, he was the President of Win Buyer Ltd.  He has served on the board of directors of a number of Israeli publicly traded and privately-held Israeli companies including, among others, Velox Ltd., NESS Ltd. (acquired by BioNess Inc.), Idanit (acquired by Scitex Corporation Ltd.), Objet Geometrix (merged with Stratasys, Inc.), Verisity, Scitex Vision (acquired by Hewlett Packard), Golden Wings Investment Company Ltd., the venture capital fund of the Israeli Air Force Veterans Business Club, Win Buyer Ltd. and Sun Light Ltd.  He received his B.Sc. in Electrical Engineering from the Technion, Israel in 1978 and M.B.A. from the Tel Aviv University in 1981.  He holds the highest award from the Israeli Air Force for technological achievements.

Aharon Schwartz, PhD

Director
-more-

Dr. Schwartz has served as our director since November 2014.  He retired from Teva in 2011 where he served in a number of positions from 1975 through 2011, the most recent being Vice President, Head of Teva Innovative Ventures from 2008.  Dr. Schwartz is currently chairman of the board of directors of BiolineRx Ltd. and a member of the board of directors of Barcode Ltd and Foamix Pharmaceuticals Ltd.  He also works as an independent consultant.  From January 2013 through November 2017, he served as a member of the board of directors of Alcobra Ltd., which is now called Arcturus Therapeutics Ltd.  Dr. Schwartz received his Ph.D. in organic chemistry in 1978 from the Weizmann Institute of Science, his M.Sc. in organic chemistry from the Technion and a B.Sc. in chemistry and physics from the Hebrew University of Jerusalem.  Dr. Schwartz received a second Ph.D. in 2014 from the Hebrew University of Jerusalem in the history and philosophy of science.